ArticleScientific reports2025
Chronic adulthood exposure to bisphenol A causes behavioral changes via suppressing dopamine transporter trafficking.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Protective effects of gastrodin against bisphenol A-induced dopaminergic dysregulation and cognitive impairment in rats.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence suggests that early life exposure to Bisphenol A (BPA) may impact neurobehavioral development in animals. BPA has been linked to changes in the dopamine level in the brain. However, molecular and cellular details of how BPA exposure causes these behavioral and cognitive outcomes are poorly understood. We examined how BPA affects the behaviors of adult mice and found that BPA induced hyperactivity and abnormal reward feedback in mice exposed at the early adult stage. We hypothesized that BPA might cause hyperactivity in mice by suppressing DAT trafficking. Fluorescence microscopy revealed that YFP-DAT remains in the perinuclear area when treated with BPA, compared to broader distribution throughout the cytoplasm in control cells. Results from MPTP toxicity and APP + uptake assays indicate that the surface expression of DAT was reduced by BPA treatment. Immunofluorescence staining of neurons in the Substantia nigra (SN) area of the mouse brain also revealed that DAT remains in the perinuclear region, indicating lower surface expression of DAT in the SN, playing important roles in reward and movement. We used another in vivo model, C. elegans, expressing GFP-tagged DAT-1 fusion protein and found that exposure to 50 µM BPA induced a significant increase in the frequency of body bends. However, the frequency of body bends was significantly reduced at 100 µM BPA, indicating biphasic effects of BPA. In conclusion, our results suggest that BPA contributes to the alterations of mice and worm behavior by reducing DAT expression on the surface of neurons via blocking of DAT trafficking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.